M:NYSEMacy's Inc Analysis
Data as of 2026-04-16 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Macy's (M) is trading at $19.15, just shy of the near‑term resistance of $19.58 and comfortably above the 20‑day SMA of $18.33, indicating limited upside in the immediate window. The MACD histogram is positive and the signal line turned bullish, while the RSI sits at a neutral 56, suggesting no imminent overbought pressure. Fundamental metrics show a low trailing P/E of 8.25 and a price‑to‑book of 1.04, positioning the stock in the value space, and the dividend yield of 4% with a modest 31% payout ratio underscores decent cash return potential. However, revenue slipped 1.1% year‑over‑year, operating margins remain thin at 7.5%, and the balance sheet is leveraged with a debt‑to‑equity of 114%, flagging financial risk. Volatility is elevated at 35% over the past 30 days and beta around 1.33 points to higher systematic risk, while volume trends are weakening, hinting at waning short‑term buying interest. Analyst consensus remains neutral with a median price target of $20, implying only a modest 1.3% upside, and a DCF‑derived fair value of $5.9 starkly contrasts the current price, raising questions about valuation methodology. Overall, the stock presents a mixed picture: attractive valuation and dividend income against a backdrop of earnings pressure, high leverage, and sector cyclicality.
Market Outlook
Short Term
< 1 yearKey Factors
- Price hovering near resistance with decreasing volume
- Bullish MACD but neutral RSI
- Elevated short‑term volatility
Medium Term
1–3 yearsKey Factors
- Recent earnings beat and solid dividend yield
- Low valuation multiples relative to peers
- High leverage and modest revenue decline
Long Term
> 3 yearsKey Factors
- Attractive P/E and P/B for a value play
- Sustainable dividend with ample coverage
- Potential upside if leverage is reduced and sales stabilize
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.